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Arthropod-borne viruses (arboviruses) have been responsible for some of the most explosive epidemics of emerging infectious
diseases over the past decade. Their impact on both human and livestock populations has been dramatic. The early detection
either through surveillance or diagnosis of virus will be a critical feature in responding and resolving the emergence of such
epidemics in the future. Although some of the most important emerging arboviruses are human pathogens, this paper aims to
highlight those diseases that primarily aﬀect livestock, although many are zoonotic and some occasionally cause human mortality.
This paper also highlights the molecular detection methods speciﬁc to each virus and identiﬁes those emerging diseases for which
a rapid detection methods are not yet developed.
1.Introduction
In 1983, Odend’ Hal [1] published a short book listing
the worldwide distribution of animal viruses. It reported
the classiﬁcation as well as host, historical movements, and
diagnostic techniques available. Of the 110 viruses cited, 35
werearboviruses,thosevirusesthataretransmittedprimarily
by an arthropod vector. This ﬁrst attempt at mapping animal
viruses provides a useful baseline for reviewing the current
state of arboviruses of livestock. Arboviruses are mainly
classiﬁed to the virus families Bunyaviridae, Togaviridae,
Reoviridae, and Flaviviridae [2]. The majority of these virus
families have a ribonucleic acid genome, with the clear
exception of the Asfarviridae to which African swine fever
virus belongs (Table 1).
In Table 2 an updated list of arthropod-borne virus
pathogens of humans, livestock, and wildlife is provided.
During recent years several pathogenic arboviruses have
apparently dispersed to new locations. The most well-known
cases have been the movement of West Nile virus from
the Old world to the New World [3] and the introduction
of bluetongue virus into northern Europe [4]. This has
prompted a wide range of authors to review the potential
viruses that could emerge in the UK and Europe and assess
the risk of such emergence events in the future [5–9].
The cooler climate experienced in northern latitudes
(above 50◦) means that there are fewer species and less
diversity among particular arthropod species and the viruses
they harbour than found in subtropical and tropical regions.
Currently, there are few arthropod-borne diseases of live-
stock in Europe and as a result, livestock in the UK and
many areas of northern Europe may be highly susceptible to
many arthropod-borne viruses listed in Table 2. The health
impact of an emergence of one could likely be severe. An
exception to this is the presence of louping ill virus, which is
considered to be the only arbovirus of veterinary importance
that is endemic within the UK. The virus has been present
forhundredsofyearsandisrestrictedtomoorlandlocations,
particularly in Devon, Cumbria, Wales, and Scotland [10].
This tick-borne virus causes fatal encephalitic disease in
sheep, although it has been reported in a range of other
species. A number of reports have suggested that West
Nile virus and two other mosquito-borne viruses had been
introduced into the UK, although cases of disease in horses
have not been reported [11]. This is in clear contrast to
the situation in Italy where WNV has repeatedly emerged2 Journal of Biomedicine and Biotechnology
Table 1: Details of selected arbovirus families.
Virus family Enveloped Genome (sense) Segmentation (number) Example virus
Bunyaviridae Yes RNA SS1 (−)3 R i f t V a l l e y f e v e r
Flaviviridae Yes RNA SS (+) Nonsegmented Dengue virus
Reoviridae No RNA DS2 10–12 Bluetongue virus
Rhabdoviridae Yes RNA SS (−) Nonsegmented Vesicular stomatitis virus
Togaviridae Yes RNA SS (+) Nonsegmented Chikungunya virus
Asfarviridae Yes DNA DS Nonsegmented African swine fever virus
Orthomyxoviridae Yes RNA SS (−) 8 Thogoto virus
1Single-stranded.
2Double-stranded.
to cause neurologic disease in horses from the Tuscany
Region [12]. Recurring outbreaks of disease have occurred
in both livestock and humans suggesting the permanent
establishment of this virus in the mosquito population [13].
This has made assessment of future climate change trends
essential to understanding the impact on both the ecology
of the UK and risk of vector-borne disease introduction
and establishment [9]. Such changes might enhance the
establishment of invasive arthropod species such as the Asian
t i g e rm o s q u i t o( Aedes albopictus) that in turn could directly
import an exotic virus. It could also boost the population of
indigenousvectorsthatcouldinturnincreasethenumbersof
bitingevents,enhancingthelikelihoodofvirustransmission.
Furthermore, increases in temperatures can shorten the
extrinsic incubation period, the time between the vector
taking a blood meal and becoming infectious to a new host,
thus enhancing virus persistence in a new area.
A wide range of routes would enable arthropod-borne
viruses to translocate into a disease-free area. These can
be divided into those that are part of the normal ecology
and are inﬂuenced by the environment and climate that are
presumably occurring all the time. Avian migration is an
example of this pathway. Avian species are known to harbour
many pathogens [14] and certain viruses such as avian
inﬂuenzaandNewcastlediseasevirusaretransmittedaround
the globe through bird migration. For arthropod-borne
viruses, virus movement can occur via transportation of the
vector [15] or through infection of the host, particularly a
viraemic animal that is subsequently fed on by an arthropod
in a disease-free destination. The range of Crimean-Congo
haemorrhagic fever appears to be increasing slowly in
south-east Europe associated with spread by its tick vector
(Hyalomma spp.). Bluetongue virus transmission into the
UKisbelievedtohaveresultedfromdirectintroductionofits
midge vector (Culicoides spp.) assisted by wind movements
in 2007 [16]. It is likely that movements by these routes, if
they happen, are occurring continuously and cannot realis-
tically be controlled. Therefore, eﬀort needs to be directed
towards reducing the impact of introduction. The alternative
to natural introduction is often mediated by the actions of
man. Again, this could occur through passive introduction
of the vector through the movement of humans, livestock,
or trade goods between endemic and disease-free areas or
by the movement of infected livestock between countries.
Theoretically, these mechanisms of entry can be regulated
and eﬀort should be directed to prevention programs.
A key aspect in preparing for the emergence of ar-
thropod-borne diseases is the establishment of tests capable
of detecting them. Development of such tests needs to
address a number of fundamental issues. These include key
features such as sensitivity of the assay and its speciﬁcity for
the target virus. The assay must also be validated to provide
assurance of its reliability, or at least give an indication of
what might be missed. The assay under development needs
to compete with existing technologies in terms of cost and
speed to deliver desirable beneﬁts to encourage adoption.
The application of a particular test needs to be considered.
Some tests may be applied to surveillance for virus, in which
case the test needs to be amenable to cost-eﬀective delivery
of high volumes of samples. This in turn can complement
serosurveys for particular viruses or be applied to sampling
arthropod vectors in order to provide early warning of
potential disease incursion.
For some technologies, the cost of individual tests is
prohibitive for application to large numbers of samples or
in resource-poor areas such as Africa. In each of these areas,
molecular detection techniques have been very competitive
as evidenced by the numerous tests developed in recent
decades. Many of the assays reported in this paper provide
a result considerably faster than more traditional detection
methods such as virus isolation and plaque-reduction neu-
tralization tests. Genetic variability of viruses is an inherent
weakness in the use of molecular detection techniques with
primer-mismatch being a constant problem. This has to
some extent been overcome by the wealth of sequence data
now available on many of the viruses that aﬀect livestock.
Here we provide an overview of those arthropod-borne
viruses that cause clinical disease in livestock and lead to eco-
nomic losses. It will not consider important arboviruses that
cause signiﬁcant human disease with no livestock involve-
ment such as yellow fever, dengue, Toscana virus, and chik-
ungunya virus. Background information on the disease
causedby particular viruses is described, the main arthropod
vector and the reported current geographical distribution is
provided for the viruses selected. This is followed by a brief
review of reported rapid molecular tests that detect speciﬁc
viruses or those tests that detect virus groups that contain
numbers of animal pathogens.Journal of Biomedicine and Biotechnology 3
Table 2: Pathogenic arboviruses (viruses in bold are dealt with in greater detail later in the paper).
Virus Classiﬁcation:
family genus Vector Animals aﬀected Disease
(SFI1,H F 2,E 3) Endemic presence OIE∗
listed
African horsesickness
virus
Asfarviridae
Asﬁvirus Midge (Culicoidesspp.) Horses SFI/HF Africa Yes
Africanswinefever
virus
Reoviridae
Orbivirus Ticks (Argasid spp.) Pigs HF Africa Yes
Akabane virus Bunyaviridae
Orthobunyavirus
Mosquito(Aedes spp.)
and midges
Cattle, sheep,
horse,
Congenital
abnormalities
EastAsia,Turkey,
SouthAfrica No
Bluetonguevirus Reoviridae
Orbivirus Midge (Culicoidesspp.) Cattle, sheep, goat HF Americas,Africa,
Asia Yes
Bovineephemeral fever
virus
Rhabdoviridae
Ephemerovirus Midge/mosquito Cattle SFI/respiratory Africa, Asia,
Australia No
California encephalitis
virus
Bunyaviridae
Orthobunyavirus Mosquito Humans, small
mammals EA m e r i c a s N o
Chikungunya virus Togaviridae
Alphavirus Mosquito (Aedes spp.) Humans SFI Africa, Asia, Europe No
Colorado tick fever
virus
Reoviridae
Coltivirus
Tick (Dermocentor
andersonii)
Humans, small
mammals SFI North America No
Crimean-Congo
haemorrhagic fever
virus
Bunyaviridae
Nairovirus Ticks (Hyalomma spp.) Humans SFI/HF Africa,Asia,Europe No
Dengue virus Flaviviridae
Flavivirus Mosquitoes (Aedes spp.) Humans SFI/HF Africa, Asia,
Americas, Europe No
Dugbe virus Bunyaviridae
Nairovirus Ticks Humans, cattle SFI Africa No
Easternequine
encephalitis virus
Togaviridae
Alphavirus
Mosquitoes(Culex
spp.) Humans, equine E Americas Yes
Epizootic
haemorrhagicdisease
virus
Reoviridae
Orbivirus Midge (Culicoidesspp.) Cattle, deer HF Americas,Africa,
Asia Yes
Equine encephalosis
virus
Reoviridae
Orbivirus Midge (Culicoidesspp.) Equine E SouthernAfrica,
Israel No
Getah virus Togaviridae,
Alphavirus Mosquito (Culex spp.) Equine SFI/E Asia No
Inkoo virus Bunyaviridae
Orthobunyavirus Mosquito (Aedes spp.) Cattle SFI Finland No
Japanese encephalitis
virus
Flaviviridae
Flavivirus Mosquito(Culex spp.) Humans,pigs,
horses E/abortion Asia Yes
Kemerovo virus Reoviridae
Orbivirus Tick (Ixodes spp.) Humans, rodents,
birds SFI Asia No
Kyasanur Forest virus Flaviviridae
Flavivirus
Ticks (Haemaphysalis
spp.)
Humans, small
mammals E India No
La Crosse virus Bunyaviridae
Orthobunyavirus Mosquito (Aedes spp.) Humans, Small
mammals E North America No
Loupingillvirus Flaviviridae
Flavivirus Ticks (Ixodes ricinus) Sheep, cattle E BritishIsles No
Murray Valley
encephalitis virus
Flaviviridae
Flavivirus
Mosquito (Culex
annulirostris)
Humans, horse,
cattle E Australia, Indonesia No
Nairobisheep disease
virus
Bunyaviridae
Nairovirus
Tick (Ripicephalus
appendiculatus) Sheep, goats HF/gastroenteritis East Africa Yes
Omsk Haemorrhagic
fever virus
Flaviviridae
Flavivirus
Tick (Dermacentor
reticulatus) Humans HF Asia No
Palyam virus Reoviridae
Orbivirus Mosquitoes, midges Cattle Abortion Africa, Asia and
Australia No
Peruvian horse sickness
virus
Reoviridae
Orbivirus Mosquitoes Horses E South America No
Powassan virus Flaviviridae
Flavivirus
Mosquito
(Aedes/Anopheles spp.)
Small/medium
sized mammals
North America,
Russia No4 Journal of Biomedicine and Biotechnology
Table 2: Continued.
Virus Classiﬁcation:
family genus Vector Animals aﬀected Disease
(SFI1,H F 2,E 3) Endemic presence OIE∗
listed
RiftValley fever virus Bunyaviridae
Phlebovirus Mosquito(Aedes spp.) Humans,sheep,
goats,camels SFI/HF/abortion Africa Yes
Russian spring-summer
encephalitis virus
Flaviviridae
Flavivirus Tick (Ixodes persulcatus) Humans, cattle,
goats E Eurasia No
Sandﬂy fever virus Bunyaviridae
Phlebovirus
Sandﬂy (Phlebotomus
perniciosus) Humans SFI Europe No
Sindbis virus Togaviridae,
Alphavirus Mosquito Wildlife, avian SFI Africa, Europe, Asia No
St. Louis encephalitis
virus
Flaviviridae
Flavivirus Mosquito (Culex spp.) Humans, avian E Americas No
Semliki Forest virus Togaviridae
Alphavirus Mosquito (Aedes spp.) Equine E Africa No
Tahyna virus Bunyaviridea
Orthobunyavirus Mosquito (Aedes spp.) Humans, pigs SFI Africa, Europe No
Tick-borne encephalitis
virus
Flaviviridae
Flavivirus Tick (Ixodes spp.) Humans, wildlife E Europe, Asia No
Thogoto virus Orthomyxoviridae
Thogotovirus Tick (various spp.) sheep Abortion Africa No
Usutu virus Flaviviridae
Flavivirus Mosquito Avian, humans E Africa, Europe No
Venezuelan equine
encephalitis virus
Togaviridae
Alphavirus Mosquito Humans, horse E Americas Yes
Vesicularstomatitis
virus
Rhabdoviridae
Vesiculovirus
Mosquito/sandﬂy/
midges/blackﬂy
Humans,cattle,
horse,pigs Mucosal vesicles Americas Yes
Wesselsbron virus Flaviviridae
Flavivirus Mosquito(Aedes spp.) Humans,sheep,
cattle HF Africa,Asia No
West Nile virus Flaviviridae
Flavivirus Mosquito(Culex spp.) humans,cattle,
horse,avian E Africa,Eurasia,
Americas Yes
Western equine
encephalitis virus
Togaviridae
Alphavirus Mosquito Humans,cattle,
horse E Americas Yes
Yellow fever virus Flaviviridae
Flavivirus
Mosquito (Aedes and
Haemagogus spp.) Humans, primates HF Africa, South
America, Caribbean No
1SFI: systemic Febrile Illness; 2HF: haemorrhagic fever; 3E: encephalitis.
∗Oﬃce International des Epizooties (World Organisation for Animal Health).
2.VirusesAssociatedwith
Transmission by Midges
2.1. Bluetongue Virus
2.1.1. Clinical Disease. Bluetongue (BT) is a disease of
ruminants with sheep being the most susceptible and
aﬀected species and cattle being aﬀected to a lesser extent.
Asymptomatic infections have been recorded in various
other species such as deer, alpaca, llamas, and goats [17–19].
Since the emergence of BTV serotype 8 in northern Europe,
signiﬁcant clinical disease in cattle herds and goats has
been reported [20]. The incubation period from exposure to
disease is between two and ﬁfteen days, averaging around 6
days[21].Insheep,diseaseisﬁrstcharacterisedbyafeverand
salivation, which develops into a more severe form causing
mucopurulentdischargefromthenasalpassagesandoedema
of face and lips. The tongue may become cyanotic hence
the name bluetongue and haemorrhages can form on the
coronary band. Oral lesions can become haemorrhagic and
ulcerative [21]. In aﬀected cattle, crusts and erosions are
visibleonthenasalandoralmucosa,inoraroundthenostrils
and lips. Other signs include salivation, fever, conjunctivitis,
muscle necrosis, and stiﬀness in limbs.
2.1.2. Geographical Distribution. BTV is endemic through-
out the world with the total of 24 serotypes circulating across
the globe. In 2007, a new Orbivirus, Toggenburg virus, was
isolated from goats in Switzerland and is now characterised
as a tentative 25th serotype of bluetongue virus [22]. A
further serotype has been detected in the Middle East [23].
Bluetongue virus was ﬁrst reported in Africa when the
disease was described in European Merino sheep that had
been introduced into the Cape Colony [21]. Historically,
the disease has predominantly been found between latitudes
40◦Nand35 ◦Suntil 1998 whenthevirusenteredEuropeand
caused repeated outbreaks involving mainly ﬁve serotypes
(BTV-1, BTV-2, BTV-4, BTV-9, and BTV-16) around the
Mediterranean Basin aﬀecting 12 European countries, three
North African countries, and Israel [24]. In 2006, BTV-8Journal of Biomedicine and Biotechnology 5
emerged in northern Europe with outbreaks in most western
European countries and as far north as Denmark and south-
ern Sweden [25]. BTV-8 emerged in south-east England in
2007 and spread to locations throughout the UK. However,
the UK government introduced a voluntary vaccination
programme in 2008, which controlled the disease and no
further outbreaks have been reported within the UK [26].
In 2008, small localised outbreaks of BTV serotype-6 were
reported in cattle herds in the Netherlands and Germany
[27].ThiswasthesecondserotypetobypasssouthernEurope
and emerge directly to northern Europe.
2.1.3. Vector. The only known biological vectors of blue-
tongue virus are the biting midges of the Culicoides genus.
The most widespread vector is Afro-Asiatic C. imicola,w h i c h
is distributed in Asia, the Middle East, most of Africa,
and in southern and eastern Europe [28]. The absence
and scarce distribution of C. imicola during the bluetongue
outbreaks in Italy in 2000 onwards led to a search for
novel vectors for virus transmission. Light-trapping and RT-
PCR experiments identiﬁed the C. pulicaris and C. obsoletus
complex(C.obsoletusss.,C.chiopterus,C.dewulﬁ,C.scoticus)
as potential vectors [29]. Later, ﬁeld studies during the 2006
outbreak in Northern Europe also found no C. imicola in
traps, but identiﬁed C. dewulﬁ, C. obsoletus, and C. scoticus
as possible vectors [30]. In addition, these species have a
palearctic distribution and they are known to be widespread
throughoutEurope.ThehighparityratesofC.dewulﬁandC.
obsoletus complex observed in Netherlands further supports
the possibility of these species playing a role in bluetongue
transmission [31]. These observations suggest that more
than one species of midge are responsible for bluetongue
virus distribution.
2.1.4. Molecular Diagnosis. Since the early 1990’s, a range
of RT-PCR assays targeting diﬀerent BTV genome segments
have been developed with a common drawback that they
were only able to detect a limited number of serotypes [32–
37]. Furthermore, most of these methods required the use
of agarose gel electrophoresis for nucleic acid detection,
which made them laborious and unpractical for diagnostic
purposes. However, the spread of BTV in Northern Europe
has seen the reporting of a number of conventional [38]
and real-time RT-PCR assays detecting all 24 serotypes
simultaneously [39–41]. These assays have been designed
for diagnostic requirements; they are all rapid, reliable, and
sensitive, enabling high throughput testing, which can be
applied directly to clinical samples. The genome of blue-
tongue virus consists of ten double-stranded RNA segments
coding for seven structural and three nonstructural (NS)
proteins [42]. Several of these genome segments are highly
conserved within serotypes, which make them potential
targets for molecular detection. All recently published real-
time RT-PCR and traditional RT-PCR assays use diﬀerent
BTV genome segments as a target. Orr` ua n dc o w o r k e r s[ 37]
designed an assay targeting genome segment 10 (encodes
NS3) using a stem-loop Molecular Beacon (MB) ﬂuorescent
probe. The probe can be used for both real-time RT-PCR
detection and quantiﬁcation purposes. Two groups have
published duplex assays using two primer sets, where one
assay targets BTV genome segment 7 (encoding the main
BTV-speciﬁcantigen,VP7)andtheothertargetsthesegment
1 (encoding the viral polymerase, VP1) [39]. Using genome
segment 1 as a target not only allows detection of all 24
serotypes, but will also detect geographic variants within
individual serotypes by diﬀerentiating the samples to eastern
(Middle-East, Asia, Australasia) and western (Africa, The
Americas) genotypes [39]. Considering the high genetic
variability through reassortment and mutations of RNA
viruses, it is possible that current real-time RT-PCR assays
m i g h tf a i lt od e t e c ts o m es t r a i n so fB T Vi nt h ef u t u r e .T o
address the problem of the genetic variability of BTV, the
most recent real-time RT-PCR assay is based on the primer-
probe energy transfer (PriProET) which is characterised by
its tolerance towards mutations in probe region [42]. This
assay is designed to detect all 24 serotypes.
2.2. African Horse Sickness Virus
2.2.1. Clinical Disease. African horse sickness virus (AHSV)
is the causative agent of African horse sickness, a disease
of Equidae with a high level of mortality. Horses are the
most aﬀected species whereas mules and donkeys show mild
clinical signs or no signs at all, and zebras are considered
a natural host and reservoir for AHSV [43]. Based on
clinical and pathological ﬁndings, African horse sickness can
manifest in fourforms ranging from mild symptoms with no
mortality to a severe disease with 95% mortality rate [43].
The mildest form, horse sickness fever, is characterised by
mildtomoderatefeverlastingupto5daysandaﬀectingmost
commonly the African donkey. A cardiac (subacute) form is
recognised by long-lasting fever, oedema of the head, neck,
chest, or supraorbital fossae and petechial haemorrhages in
the eyes and tongue with mortality rates around 50%. The
most severe manifestation with highest mortality rates is
a pulmonary (peracute) form, which is characterised by a
rapid onset of disease. Death can occur without previous
indication of illness or an animal can show signs of fever,
depression and respiratory distress. The most commonly
seen clinical presentation is a mixed (cardiac-pulmonary)
formwhichcanr eachmortalityratesashighas70%3–6da ys
after onset of fever.
2.2.2. Geographical Distribution. The virus is currently
endemic in subtropical and tropical areas of Africa below
the Saharan desert, which seems to provide a natural barrier
against spread northwards [43] .N i n es e r o t y p e sh a v eb e e n
recognised which all have been reported in southern and
eastern Africa. Serotypes 4 and 9 are found in western Africa
andaretheonlyserotypesthathavecausedoutbreaksoutside
of Africa. The major outbreaks outside Africa have so far
occurred in the Middle East, Spain, and Portugal. Spain
has experienced ﬁve outbreaks of African horse sickness
since 1966 [44]. The ﬁrst outbreak in 1966 started from
Gibraltar and was caused by serotype 9, which resulted in
637animalsdyingorbeingslaughtered.In1987,anumberof
subclinically infected zebras were imported into a Safari park
near Madrid, which caused four further outbreaks between6 Journal of Biomedicine and Biotechnology
1987 and 1990. However, these outbreaks were due to
serotype 4 of AHSV. This was the ﬁrst time that a serotype
other than 9 had been recorded north of the Sahara desert.
BeforetheeradicationofthevirusinSpainattheendof1991,
the outbreaks resulted in over 1300 horses dying or being
destroyed and the virus spreading into Portugal, Tunisia, and
Morocco [45].
2.2.3. Vector. Like bluetongue virus, African horse sickness
virus is spread by biting midges of the Culicoides genus.
The major vector for transmission is C. imicola, but also
C. bolitinis has been shown to play a role in virus spread
[46]. In 1998, over 100 horses died in an isolated population
in Clarens Valley in South Africa and AHSV was isolated
from the most locally abundant midge species, C. bolitinis,
collected during light trap studies. It has been suggested that
other Culicoides species might be involved, especially where
low-grade cycling of virus is occurring.
2.2.4. Molecular Diagnosis. The ﬁrst RT-PCR assays for
AHSV detection and serogroup identiﬁcation were time
consuming and labour intensive procedures which involved
either restriction fragment length polymorphism (RFLP) or
dot-blot hybridisation assays [47–49]. These were followed
by several conventional RT-PCR assays, which still required
gel-based visualisation and took between four and six
h o u r st oc o m p l e t e[ 50–52]. However, a huge improvement
in molecular diagnosis has occurred during recent years,
resulting in numerous real-time RT-PCR assays that are able
to detect, quantify, and discriminate the serotypes of AHSV
in a short period of time [53–57]. Currently AHSV is only
endemic in Africa, where laboratory conditions vary and
real-time RT-PCR equipment can be too costly. Therefore,
some studies have aimed to develop both real-time RT-
PCR and conventional RT-PCR in parallel or solely improve
conventional RT-PCR to provide better and faster diagnostic
tools that are available in all circumstances [58]. These
studies have shown high sensitivity and speciﬁcity of both
conventional and real-time RT-PCR assays for all nine
serotypes.DetectionlimitforbothconventionalandTaqMan
real-time RT-PCR has been reported to be 1.2TCID50/mL
[55]. More importantly new, improved RT-PCR assays can
provide results within three hours of sample receipt.
2.3. Epizootic Haemorrhagic Fever Virus
2.3.1. Clinical Disease. Epizootic haemorrhagic fever virus
(EHDV) causes a haemorrhagic disease in ruminants, espe-
cially in white-tailed deer in America and in cattle elsewhere.
The clinical signs are often similar to those caused by
bluetongue virus which complicates diagnosis. The clinical
signsreportedincattleincludereductioninmilkproduction,
fever, loss of appetite, weakness, excessive nasal and ocular
discharge, oral ulcerations, discolouration of the udder, and
oedema of hooves [59].
2.3.2. Geographical Distribution. There are currently ten ser-
otypes of EHDV circulating throughout the world. EHDV-1
was ﬁrst isolated in white-tailed deer in New Jersey in 1955
and it is still the most important infectious disease in deer
in North America. All serotypes have caused clinical disease
in cattle across the globe including North America, Africa
(northandsouth),Australia[60],theislandofR´ eunion[61],
and Japan. Recent outbreaks have been reported around the
Mediterranean including Morocco, Algeria, Israel in 2006,
and Turkey in 2007 [62].
2.3.3. Vector. Culicoides spp. transmit the disease between
ruminant hosts.
2.3.4. Molecular Diagnosis. The earliest EHDV RT-PCR
assays have been based on American isolates, mainly on
serotypes 1 and 2 targeting diﬀerent genomic segments [63–
65]. Since the spread of EHDV into new territories, the
RT-PCR assays reported have been type-speciﬁc rather than
serotype speciﬁc or even multiplex RT-PCR assays that can
simultaneously detect both bluetongue and EHDV [66, 67].
A real-time RT-PCR has been reported that detects eight
serotypes of EHDV [68].
2.4. Bovine Ephemeral Fever Virus
2.4.1. Clinical Disease. Bovine ephemeral fever virus (BEFV)
causes disease in domestic cattle and water buﬀalo [69].
The disease is also known by the names 3-day sickness, stiﬀ
sickness,bovineepizooticfever,lazyman’sdisease,ordengue
of cattle. The clinical outcome can vary from inapparent
infection to death, but generally disease has four main
phases. After an incubation period of between one and ten
days, disease begins with a sudden fever that can be bi-,tri-
, or polyphasic with peaks 12 to 18 hours apart. Fever lasts
around half a day before the infected animal may become
depressed and reluctant to move. Mucous discharge from
the nose and profuse salivation can be observed and milk
production is reduced or ceased altogether. This period of
disability usually lasts between one and two days after which
most animals start to recover. Although mortality rates as
high as 30% have been observed, in most uncomplicated
cases it is less than 2%. Sequelae include reduced milk
production and other complications include pneumonia,
mastitis,abortioninlatepregnancyandtemporaryinfertility
of bulls [70].
2.4.2.GeographicalDistribution. Thebovineephemeralfever
was ﬁrst recognised in Zimbabwe in 1906. The current
distribution of BEFV includes all of Africa, the Middle East,
Asia, and Australasia [71]. The outbreaks in the Middle East
haveoccurredinSaudiArabiaandIsrael[72,73].Thedisease
has not been reported in Europe or the Americas.
2.4.3. Vector. Epidemiological studies indicate that BEFV is
transmitted through ﬂying insects. No arthropod vector has
been shown to transmit the virus, but it has been isolated
from Culicoides midges in Kenya and mosquitoes (Culicine
mosquito species and Anopheles bancroftii)i nA u s t r a l i a[ 74,
75].Journal of Biomedicine and Biotechnology 7
2.4.4. Molecular Diagnosis. Currently, virus isolation seems
to be the standard method for bovine ephemeral fever
diagnosis and only two molecular diagnostic assays detecting
BEFV have been reported. Real-time RT-PCR has been
developed by Stram and coworkers [76], whereas Zheng
and coworkers [77] reported the development of reverse
transcription loop-mediated isothermal ampliﬁcation (RT-
LAMP) method. Both assays target the G gene and are highly
sensitive assays, real-time RT-PCR being able to detect 10
BEFV genome copies in a sample [76]. The advantage of RT-
LAMP is that no specialist equipment is required as there is
no requirement for thermal cycling. However, a range of spe-
cialist apparatus is now available speciﬁcally for application
with RT-LAMP such as lateral ﬂow devices and turbidome-
ters.
2.5. Akabane Virus
2.5.1. Disease. Akabane is a disease of ruminants. In adults
the disease is generally asymptomatic with a transient
viraemia occurring between one and six days after infection,
which lasts for about six days. Occasional cases of enceph-
alomyelitis have been observed in some infected animals
[78]. The main economic impact of Akabane virus results
from abortions, stillbirths, and congenital abnormalities that
aﬀect pregnant animals. Abnormalities vary depending on
the trimester when infection occurs, although most are
severely aﬀected and euthanized shortly after birth.
2.5.2. Geographical Distribution. The disease occurs between
latitudes 35◦Na n d3 5 ◦S[ 79]. Serological evidence indicates
that the virus is present throughout Africa, Asia, and the
northern half of Australia. Disease has been observed in
South Africa, Cyprus, the Middle East, and Japan.
2.5.3. Vector. Akabane virus has been isolated from Culi-
coides spp. in Australia (C. brevitarsis and C. wadei),A f r i c a
(C. milnei and C. imicola), Japan (C. oxystoma), and a
number of mosquito species including Aedes vexans, Culex
tritaeniorhynchus and Anopheles funestus.
2.5.4. Molecular Diagnosis. The genome of Akabane virus,
like other orthobunyaviruses, is segmented, consisting of a
small (s), medium (m), and large (l) segments. Standard RT-
PCR assays have been described for detection of Akabane
virus that target the S segment of the virus [78, 80]. A further
development has been to incorporate detection of Akabane
virus with that of Aino virus, a causative agent of congenital
defects in cattle. This combined assay takes the format of a
real-time multiplex RT-PCR that also targets the S segment
[81]. The limit of detection is reported to be between 3 and
30 genome copies.
2.6. Equine Encephalosis Virus
2.6.1. Disease. Equine encephalosis virus (EEV) causes an
acute disease in horses with a high fever and depressed
appetite. A characteristic of the disease is the swelling of the
lips and eyelids. Neurological disease is common and abor-
tion can result from infection. Clinical features such as
oedema are similar to those observed for AHSV and this
should be considered in the diagnosis. However, fatalities are
rare, particularly when supportive treatment is provided.
2.6.2. Geographical Distribution. The virus was originally
isolated in South Africa and seven serotypes have been
reported within the country [82]. A recent report has
suggested the emergence of EEV in Israel [83].
2.6.3. Vector. Culicoides spp. are implicated in the transmis-
sion of this virus [84].
2.6.4. Molecular Diagnosis. No speciﬁc RT-PCR assays have
been reported for equine encephalosis virus.
2.7. Vesicular Stomatitis Virus
2.7.1. Disease. Vesicular stomatitis virus (VSV) causes dis-
ease in cattle, horses, and pigs and is signiﬁcant as it is clin-
ically similar to foot and mouth disease (FMD). The initial
incubation period is between two and eight days with a fever
that often goes undetected. Early signs include drooling and
frothing at the mouth. Blister-like lesions form in the mouth,
on the dental pad, the tongue, the lips, the nostrils, the
hooves, and the teats. Oral lesions can be suﬃciently painful
to cause the infected animal to refuse food and weight loss
canoccur.Infectionisnotfatal,althoughrecoveryfromacute
diseasecantaketwoweeksandulcerationcantakemonthsto
heal.
2.7.2. Geographical Distribution. The virus is endemic in
Central America and northern South America. Sporadic
outbreaks occur in the USA and western regions of South
America [85].
2.7.3. Vector. A range of haematophagus insects have been
associated with transmission of VSV including Sand ﬂies
(Diptera: Psychodidae), black ﬂies (Diptera: Simulidae),
mosquitoes (Diptera: Culicidae), and culicoides midges
(Diptera: Ceratopogonidae)[ 86]. Experimentally, only the
sand ﬂy (Lutzomyia shannoni) and the black ﬂy (Simulium
vittatum) have been shown to transmit the virus transovari-
ally or to susceptible hosts. Serological evidence suggests that
wild mammals can be infected with VSV but as yet there is
no clear wildlife reservoir for the disease.
2.7.4. Molecular Diagnosis. Multiplex, real-time RT-PCRs
have been devised to detect and diﬀerentiate diﬀerent
serotypes of VSV [86] and diﬀerentiate VSV from FMDV
within the same assay [87].
3.VirusesAssociatedwith
Transmissionby Mosquitoes
3.1. Eastern, Venezuelan, and Western Equine
Encephalitis Virus
3.1.1. Disease. All three viruses cause disease in horses and
humans [88]. This can range from asymptomatic infection8 Journal of Biomedicine and Biotechnology
to acute, sometimes fatal, encephalitis. VEEV in particular
has caused extensive epizootics in some regions of South
America (Venezuala and Colombia).
3.1.2. Geographical Distribution. EEEV has been reported
from the Eastern USA, Caribbean, South, and Central
America. WEEV has been reported from North America and
Cuba. VEEV is reported from many regions of South and
Central America.
3.1.3. Vector
EEEV. The mosquito vector varies with climate and geogra-
phy.Intemperatezones,theornithophagicCulisetamelanura
isthemainvector.Intropicalregions,EEEVhasbeenisolated
from Culex melanoconion.
WEEV. In North America Culex tarsalis is considered the
main vector of transmission between avian species. Aedes
spp. have also been implicated in transmission to mammals.
In South America Aedes albifasciatus h a sb e e nr e p o r t e da sa
vector.
VEEV. Culex melanoconion is associated with transmission
of VEEV.
3.1.4. Molecular Diagnosis. TaqMan assays for North Amer-
ican EEEV and WEEV have been described [89]. Primer
sets that detect a range of alphaviruses, including EEEV
and VEEV have been described [90], however, this was
linked to ﬁnal detection using electrospray ionization mass
spectrometry.
3.2. Japanese Encephalitis Virus
3.2.1. Disease. Japanese encephalitis virus (JEV) is asymp-
tomatic in adult pigs but causes abortion, still-birth, and
birth defects including central nervous system defects result-
ing in economic loss [91]. The virus also causes encephalitic
disease in humans with over 50,000 cases reported annually
[92]. Occasional cases in equines have been reported [93].
3.2.2. Geographical Distribution. JEV is found throughout
Asia from Pakistan to Japan [94]. There is evidence that the
virus is dispersing westwards through Asia.
3.2.3. Vector. The main vector of JEV is Culex tritaenior-
rhyncus, which favours breeding in rice paddies. C. gelidus
complex mosquitoes enable transmission to birds which
assists in maintaining the virus in the environment [95].
3.2.4. Molecular Diagnosis. Ar e a l - t i m eR T - P C R[ 96] that
targets the 3 untranslated regions has been reported with
detection to 112TCID50/mL. A multiplex real-time RT-PCR
for detection of JEV, yellow fever virus, West Nile virus,
denguevirus(serotypes1–4),andSt.Louisencephalitisvirus
has been reported [97] with a sensitivity of 2PFU/mL. Real-
time RT-LAMP [98, 99] assays have been developed for
detection of JEV with detection levels as low as 0.1PFU.
3.3. Rift Valley Fever Virus
3.3.1. Disease. Rift Valley fever virus (RVFV) aﬀects rumi-
nantswithsusceptibilityinﬂuencedbyage.Newbornanimals
are highly susceptible with adults showing less severe disease
[100]. The incubation period ranges from one to three days
followed by fever, recumbency, and haemorrhagic diarrhoea.
Mortality can reach 70%. High rates of abortion are also
associated with epidemics of Rift Valley haemorrhagic fever
(RVHF), often described as abortion storms. The virus
causes disease in humans ranging from uncomplicated
inﬂuenza-like illness to haemorrhagic fever with liver dam-
age and occasionally encephalitis.
3.3.2. Geographical Distribution. The virus is considered
endemic throughout much of Africa, although clinical dis-
ease occurs infrequently. However, sudden outbreaks with
high livestock mortality occur in many regions often follow-
ing ﬂooding. The disease was ﬁrst reported in East Africa
(Kenya and Tanzania) but is believed to have expanded its
range north, west, and south, characterised by sudden epi-
demics [101]. There has been a well-documented outbreak
of RVHF in the Arabian Peninsula associated with livestock
movements from East Africa [102].
3.3.3. Vector. Aedes spp. are the principal virus vector for
livestock and are believed to maintain the virus between
epidemics although other species are capable of acting as
bridge vectors enabling transmission during epidemics, such
as Culex spp.
3.3.4. Molecular Diagnosis. Numerous real-time RT-PCR
methods have been developed for rapid detection of RVFV
[103–106]. The detection limit of these assays is typically
between 10 and 100 genome copies. An alternative approach
is the use of reverse transcription loop-mediated isothermal
ampliﬁcation (RT-LAMP) technique [107, 108]. The detec-
tion limits of RT-LAMP assays are comparable to real-time
RT-PCR.
3.4. Wesselsbron Virus
3.4.1. Disease. Wesselsbron virus (WSLV) causes infection in
sheep and goats and is associated with abortion and con-
genital abnormalities [109–111]. In adult animals, infection
is usually subclinical, although in newborn animals clinical
disease can result after a one to three day incubation period
with fever and anorexia. Mortality can reach as high as 27%.
Infection in humans has been reported following laboratory
exposure and causes a mild inﬂuenza-like illness.
3.4.2. Geographical Distribution. Virus isolation and sero-
prevalence studies suggest that the virus is present across
Africa [112, 113].
3.4.3. Vector. Aedes spp. are considered the main vector for
Wesselsbron virus. In a recent study over 50 isolates of WSLV
were isolated from Aedes vexans collected in Mauritania and
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3.4.4. Molecular Diagnosis. No speciﬁc RT-PCR tests have
been reported, although the Wesselsbron virus genome has
been published (NCBI Reference Sequence: NC 012735).
WesselsbronviruscanbedetectedbyRT-PCRusinguniversal
ﬂavivirus primers and sequencing [114].
3.5. West Nile Virus
3.5.1. Disease. West Nile virus (WNV) causes encephalitic
disease in horses, humans and some avian species [115]. In
horses early disease consists of fever that is usually inap-
parent. Subsequent disease is neurological including ataxia,
paresis and limb paralysis leading to recumbence. Muscle
tremor and muscle rigidity may be observed. Mortality rates
vary and may be particularly high in the USA reaching over
55%.
3.5.2.GeographicalDistribution. Untilrecently,WNVwasan
Old World disease present throughout Africa and Asia with
occasionalincursionsintoEuropearoundtheMediterranean
Basin [116]. However, in 1999, the virus emerged in the
north east USA and spread throughout the Americas [117]
and has remained endemic since that time [118].
3.5.3. Vector. The principal vector for WNV is the orni-
thophilic mosquito Culex pipiens.H o w e v e r ,aw i d er a n g e
of mosquito species have been shown to support virus re-
plication and transmit virus to mammalian species [119].
3.5.4. Molecular Diagnosis. Molecular detection of WNV
has been reviewed recently by Shi and Kramer [120]. Such
assays usually detect between 40 and 100 genome copies,
although some suggest that sensitivity can be even lower
[121]. Further developments have enabled multiplexing with
other arboviral diseases [122, 123] and improved assay
sensitivity [124] suggesting that the detection limit is 0.07
genome copies/mL. RT-LAMP assays have been developed
for WNV [125] and used to detect the virus in mosquito
samples [126]. The sensitivity limit of these assays has been
reported to be approximately 0.1PFU.
4.VirusesAssociatedwith
Transmission by Ticks
4.1. African Swine Fever Virus
4.1.1. Clinical Disease. African swine fever virus infects
warthogs and bush pigs in Africa with no clinical disease,
but domestic pigs can succumb to severe infection with an
incubation period of ﬁve to ﬁfteen days [127]. The disease
can manifest in any one of four forms depending on the vir-
ulence of a strain. Highly virulent strains cause peracute and
acute infections with clinical signs of high fever, anorexia,
diarrhoea, recumbency, and general reddening of skin or
discoloration on the ventral chest and abdomen, tips of the
earsortail,andondistallimbs.Deathcanoccurwithinaday,
sometimes before obvious clinical signs. The less virulent
strains cause subacute and chronic infection. The subacute
form manifests as a mild illness with an intermittent fever
lasting approximately one month although pregnant animals
might abort. In chronic cases, low fever, pneumonia and
swelling of joints may occur. Some animals infected with low
virulence strains can seroconvert without any clinical symp-
toms. Morbidity rates can reach close to 100% in herds that
are na¨ ıve for ASFV whereas mortality rates vary, but can be
as high as 100%, depending on virulence of the strain. Those
animals that have survived acute or chronic disease can
become persistently infected and act as carriers for the virus.
4.1.2. Geographical Distribution. African swine fever has
been reported in Africa since the 1890’s and is endemic
in most parts of sub-Saharan Africa where transmission
appears in three diﬀerent forms; a sylvatic cycle, a domestic
pig cycle and a pig-tick cycle [128, 129]. In 1958, ASFV
emerged for the ﬁrst time in Europe in Portugal before
spreading to Spain in 1960, where it caused several outbreaks
until the disease was ﬁnally eradicated [130]. In 1967, virus
was detected in Italy and in 1978 ASF outbreaks occurred
simultaneously in Malta and Sardinia. Whereas disease was
eradicated from Malta and mainland Italy, ASF remains
endemic in Sardinia where it is established in free-range pigs
and wild boars. In 1998, Madagascar reported the ﬁrst case
ofAfricanswinefever[131],andfromtheyear2000onwards
virus has continued to spread into new territories including
Georgia, Iran, and Mauritius [132–134]. The Georgian
outbreak in 2007 demonstrated perfectly the emerging and
transboundary characteristics of ASFV, as within a year
virus spread from Georgia to several neighboring countries
including Armenia, Azerbaijan, and the Russian Republic of
Chechnya [132]. In the following year, virus spread to north-
western Iran where it caused an outbreak in wild boar [133].
Other short-lived, sporadic outbreaks have been reported
from France, Belgium, Netherlands, Caribbean, and South
America.
4.1.3. Vector and Transmission. The subclinical infection of
ASFV in warthogs and bush pigs is maintained by soft ticks
of the genus Ornithodoros. In Africa, the main vector is O.
moubata, whereas in Southern Europe ASFV is transmitted
byO. erraticus [135].O. moubata ismostabundantineastern
and southern Africa particularly in Cameroon, Central
African Republic, and Sudan. The most prevalent viral hosts
include warthogs, domestic pigs, and man. Although, ticks
do play a part in virus transmission, the epidemiological role
is thought to be low, especially in those areas where tick
populations are small [134]. The more likely route of virus
spread is through direct oronasal contact with an infected
animal or indirectly via fomites and contaminated pig feed.
The most recent outbreaks in previously ASFV-free areas
could have been transmitted through feed products contain-
ing infected pig meat.
4.1.4. Molecular Detection. As there is no cure or vaccine for
ASFV, slaughter is the only tool for control and eradication
of this highly contagious virus in infected areas. Therefore,
fast and reliable laboratory diagnosis is required to limit
the socio-economic burden of outbreaks. Furthermore,
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as clinical signs of African swine fever may resemble those of
other infections, especially classical swine fever. The current
OIE manual recommends Taqman real-time PCR such as
the assay developed by King and coworkers [136]. As real-
time PCRs are high throughput, sensitive, speciﬁc, and quick
to run, recent development of these assays has focused on
improvementofexistingreal-timeassaysbyapplyingvarying
PCR chemistries. This has led to several modiﬁcations of
real-time PCR including use of minor groove binding probes
or molecular beacon assays [137, 138]. A recent method has
been further developed with ﬁeld diagnostics in mind. Two
assays, a LAMP method and a linear-after-the-exponential
PCR (LATE-PCR), have both been adapted for use in ﬁeld
conditions [139, 140]. These methods could considerably
shorten the time between infection and diagnosis as there
is no requirement for samples to be transported to the
laboratory.
4.2. Crimean-Congo Haemorrhagic Fever Virus
4.2.1. Disease. Crimean-Congo haemorrhagic fever (CCHF)
is one the most important and widespread diseases caused
by tick-borne viruses. The causative agent, Crimean-Congo
haemorrhagic fever virus does not cause disease in livestock,
but vertebrates play a role in virus transmission as part of
a tick-vertebrate-tick enzootic cycle [141]. Although there
is no evidence of clinical disease in animals, contact with
viremic animals, tick bite, or crushing ticks taken from
infected animals can lead to human infection. In humans,
CCHF virus causes a disease with four phases: incubation,
prehaemorrhagic, haemorrhagic, and convalescence phases
[141]. Following the short incubation period (3–7 days),
sudden onset of fever, headaches, myalgia, and dizziness
occur[142,143].Afewdayslater,arapidlydevelopinghaem-
orrhagic period occurs, with haematomas appearing on the
skin and mucous membranes with mortality rates ranging
from 3% to 30%. The surviving patients will go through
the convalescence period lasting 9-10 days which can include
variable symptoms such as tachycardia, temporary hair loss,
poorvision,andlossofappetite.Infectedhumanscanspread
CCHF via close contacts resulting in community and noso-
comial outbreaks [144–148]. Furthermore, individuals in
certain occupations such as health carers, veterinarians,
farmers, and abattoir workers are at increased risk of con-
tractingCrimean-Congohaemorrhagicfever[141,143,149].
4.2.2. Geographical Distribution. The geographic distribu-
tion of CCHF virus is the widest amongst all tick-borne dis-
eases. Currently CCHFV is endemic in Africa, Asia, Balkan
countries, and Middle and Far East [142, 145, 150]. During
the last ten years, CCHFV has been rapidly introduced into
new, previously nonendemic areas; especially into eastern
and southeastern Europe including Greece and Turkey [149,
151–153].
4.2.3. Vector. Hyalomma spp. are the vector and reservoir for
CCHFV,particularlyHyalommamarginatum.Thegeograph-
ical distribution of these ticks closely match the distribution
of CCHFV and covers southern Europe, southern Russia
extending to southern Asia, and most of Africa [154]. The
hostrangeoftheseticksvariesfromdomesticanimals(cattle,
horse, sheep, and goats) for adults to small wild animals and
birds for larvae and nymphs.
4.2.4. Molecular Detection. Since the mid 1990’s several
nested and real-time RT-PCR assays, which all target ge-
nomic S segment of the tripartite genome. These assays
have been developed to achieve fast initial and diﬀerential
laboratory diagnosis of CCHFV [104, 155–158]. Both the
nested and real-time RT-PCR assays are comparable in terms
of sensitivity, but the results can be achieved in two hours
with one-step real-time RT-PCR, whereas it takes 4-5 hours
to run nested RT-PCR without gel electrophoresis. Due to
the high genetic variability of CCHFV isolates, the ﬁrst real-
time RT-PCR assay detecting CCHFV was based on a Sybr
Green method that intercalates to any double stranded DNA
and requires identiﬁcation of the positive product using gel
electrophoresis [104]. More speciﬁc assays can be developed
by designing primers and probes directed at strains of inter-
est, for example, those circulating in geographically deﬁned
areas. Strains from the Balkan region have been successfully
identiﬁed by using a one-step real-time RT-PCR that is
based on the ﬂuorescence resonance energy transfer (FRET)
probe technology employing the endonuclease (5  → 3 )
activity of Taq polymerase enzyme [158]. Furthermore, this
assay can also be used for detection of CCHFV from ticks.
4.3. Nairobi Sheep Disease Virus
4.3.1. Disease. Nairobi sheep disease virus (NSDV) causes
acute haemorrhagic gastroenteritis in sheep and goats. This
is a severe and fatal disease with mortality rates reaching over
90 percent in non-immune animals. The short incubation
period (2–4 days) is followed by high fever, diarrhoea, and
collapse [159]. Watery to mucoid and bloody diarrhoea is
seen 2–4 days after the onset of fever which itself can last up
to 8 days. As the disease progresses nasal discharge and con-
junctivitis are common features [160]. In pregnant animals,
the infection can lead to abortion. In fatal cases, death often
occurs in the early stages of a disease. A variant of NSDV,
Ganjam virus has been isolated in India [161]. This virus is
highly pathogenic in exotic and crossbred sheep and goats
causing a disease with high fever, dullness, depression, and
loss of appetite [162].
4.3.2. Geographical Distribution. Nairobi sheep disease has
been reported since 1910 when it was ﬁrst identiﬁed near
Nairobi in Kenya [163]. NSDV is now mostly enzootic in
Kenya with the majority of indigenous sheep and goats
having protective antibodies, and outbreaks tend to occur
when ﬂocks from uninfected areas are brought into enzootic
areas[164].Furtheroutbreakshavebeenreportedfromother
countries in east and central Africa. Serosurveys suggest that
the virus may be more widespread in countries of Southern
Africa [165]. Ganjam virus, a variant of NSDV, circulates
across southern India [166].
4.3.3. Vector. In Africa, the main vector for NSDV is the
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is found between its northern limits of southern Sudan
and Ethiopia through Eastern, central and Southern Africa.
Livestock hosts for this tick include cattle, sheep, goats, and
horses [164]. In wildlife, antelopes and buﬀalo are frequently
infested.GanjamvirushasbeenisolatedfromHaemaphysalis
spp. ticks, which have been collected from sheep and goats in
India [161].
4.3.4. Molecular Detection. Primers for NSDV ampliﬁcation
have been reported [166, 167]. The complete genome
sequences of the tripartite genome of NSDV have been
published. No real-time RT-PCR has been reported.
4.4. Louping Ill Virus
4.4.1. Disease. The main forms of tick-borne encephalitis
virus (TBEV) found in Europe and Asia do not cause clinical
disease in livestock although human cases are on the increase
in Europe [168]. However, a number of closely related
variants of TBEV cause disease in livestock. These include
louping ill virus (LIV), Spanish sheep encephalitis virus
(SSEV), Greek goat encephalitis virus (GGEV), and Turkish
tick-borne encephalitis virus (TTEV). Of these, LIV is the
most studied virus as the cause of disease in sheep and red
grouse. In red grouse, LIV causes rapid and fatal encephali-
tis whereas in sheep, disease is biphasic, especially in
young nonimmune animals [169]. The initial clinical signs
of louping ill include fever and weakness before animals
develop neurological signs of disease. A range between 5 and
60% of infected animals develop clinical signs and death can
occurbetween24and48hoursfollowingthedevelopmentof
neurological signs. During the neurological phase, the most
damage is caused to the cerebellum. Clinically, the second
phase is characterized by cerebral ataxia, hyperexcitability,
and progressive paralysis [169]. Occasionally, natural infec-
tion of louping ill has also been reported from other species
such as dogs, roe and red deer, and llamas [170–173]. The
other variants are genetically distinct, but closely related to
louping ill. They are much less studied, but appear to all
cause disease that resembles louping ill [174].
4.4.2. Geographical Distribution. Tick-borne encephalitis
virus is found in many areas throughout Europe and Asia.
Transmission to humans is mainly through tick bites but
can occasionally result from consumption of unpasteurized
milk [175]. LIV is endemic within upland areas in the UK,
particularly in Scotland, Wales, the northwest and southwest
of England [169] .T h e r eh a v ea l s ob e e nr e p o r t so fL I Vi n
Ireland and Norway [176]. Sheep infected with SSEV have
been reported from the Basque region of Spain [174, 177].
The ﬁrst isolation of GGEV was made in the village of
Vergina in northern Greece [178]. Subsequent studies have
suggested that GGEV circulates in the I. ricinus population
in northern Greece, although at low density [179]. TTEV
was ﬁrst reported from northwestern Turkey (Anatolia) as
encephalitis in sheep and was subsequent conﬁrmed by
nucleotide analysis to be related to tick-borne encephalitis
virus [180–182].
4.4.3. Vector. Both TBEV and its variants are transmitted by
the three-host hard tick Ixodes ricinus in Europe. These ticks
are the most common species of ticks in northwest Europe
and are also known as the common sheep tick, castor bean
tick or wood tick. In addition to sheep and red grouse, the
hosts for I. ricinus in the UK include mountain hares, red
deer, roe deer and small mammals [183]. In the Far East of
Europe and throughout Asia, TBEV is transmitted by Ixodes
persulcatus.
4.4.4. Molecular Detection. The ﬁrst nested one-step RT-
PCR for louping ill detection was developed in mid-1990s.
This assay, which targets the envelope (E) and membrane
( M )g e n e so ft h ev i r u sg e n o m e ,c a nb eu s e df o rv i r u s
identiﬁcationinticksandotherspecies[184].AstheEgeneis
the most conserved of the three LIV structural genes, a one-
step Taqman RT-PCR assay has been developed with primers
for this protein [185]. Brain and spinal cord samples were
testedanddetectionlimitof1PFU/mLwasachieved,making
thisassayassensitiveasthetraditionalplaqueassay.Inrecent
years, real-time RT-PCR assay detecting eight diﬀerent tick-
borne ﬂaviviruses (including louping ill) and West Nile virus
has been developed in the UK [186]. The assay employs
degenerate primers targeting nonstructural protein 5 and is
based on incorporation of Sybr green. The assay is not as
sensitiveasspeciesspeciﬁcassays,butmakesitanidealchoice
when a single virus cannot be speciﬁed before testing [186].
A recently reported assay uses one-step real-time RT-PCR
with pyrosequencing which enables the rapid diﬀerentiation
between TBEV subtypes [187]. Although, this assay was
developed to diﬀerentiate between the main TBE subtypes,
it is also able to detect louping ill virus. Speciﬁc detection
assays for SSEV, TTEV, and GGEV have not been reported.
5. Conclusions
The majority of the viruses reviewed have been thoroughly
characterized and there are a wide range of molecular
diagnostic tests available. These include bluetongue virus,
AHSV, VSV, WNV, and ASFV. These tend to be those viruses
that cause the greatest impact either to livestock health or
as a consequence of spillover into the human population as
a zoonotic agent. New serotypes and variants emerge and
techniques may require modiﬁcation or augmentation in
response to genetic diﬀerences. Other viruses have molecular
tests available, but these are not widely in use, either because
many countries do not consider them necessary or do not
have suitable containment facilities to handle the virus. This
group includes EHFV, BEFV, Akabane virus, the equine
encephalitides, JEV, RVFV, CCHFV, and variants of tick-
borne encephalitis virus. Further eﬀort is needed to establish
molecular tests for these viruses more widely in preparation
for potential outbreaks. Finally, there is a small group for
whichnomoleculardiagnostictestshavebeenreported.This
includesequineencephalosisvirus,Wesselsbrondiseasevirus
and Nairobi sheep disease virus. These viruses require some
test development.
Test development and implementation could take two
forms. The ﬁrst option is to develop speciﬁc tests that detect12 Journal of Biomedicine and Biotechnology
a single virus, often at high sensitivity. The alternative is
the development of assays that detect a range of related
pathogens in single step. This has been applied to groups
including the ﬂaviviruses, alphaviruses, and phleboviruses.
The latter option has the beneﬁt of screening for more than
one pathogen. However, this approach is often less sensitive
and may require further analysis to identify the exact virus
involved.
Currently, rapid detection methods are dominated by
nucleic acid ampliﬁcation methods, particularly the poly-
merase chain reaction. By linking nucleic acid ampliﬁcation
tosequencing,itispossibletorapidlyidentifyalargenumber
of potential pathogenic viruses [114, 188]. This approach
has been applied to detection of ﬂaviviruses using universal
primers ([186], and references therein). New technologies
such as microarray [189] and next generation sequencing
[190] are being applied to the investigation of infectious
viruses. However, these technologies are expensive to estab-
lish and maintain for purely diagnostic or surveillance
purposes. Future development is required in this area to
make these technologies more accessible and aﬀordable for
use in the detection of arthropod viruses of livestock.
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